Clinical Trials Browser

Interventional × Cardiotoxicity × oblimersen × Clear all

NCT00039481 2013-01-17

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Cardiotoxicity